# Observational Lymphoma, Follicular studies: 46 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 46 trials that are observational for Lymphoma, Follicular that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lymphoma, Follicular studies: 46 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lymphoma-follicular

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 46
- Recruiting or not yet: 46
- Read on: November 19, 2026

## Trials

The 25 newest of 46, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 13, 2026 | NCT07869797 | Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer... | Mundipharma (China) Pharmaceutical Co. Ltd | Observational | Not yet recruiting | Cancer Pain | 378 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869797) |
| September 22, 2026 | NCT07834931 | PMCF Study Fortilink-TC Ti | BAAT Medical Products B.V. | Observational | Recruiting | Degenerative Disc Disease Lumbar, Spondylolisthesis, Grade 1 | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834931) |
| September 22, 2026 | NCT07834736 | PMCF Study Fortilink-TS Ti | BAAT Medical Products B.V. | Observational | Recruiting | Degenerative Disc Disease Lumbar, Spondylolisthesis, Grade 1 | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834736) |
| August 6, 2026 | NCT07750886 | Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) | Natera, Inc. | Observational | Recruiting | Non-Hodgkin Lymphoma, T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, High-Grade B-Cell Lymphoma, Primary Mediastinal... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750886) |
| May 27, 2026 | NCT07609446 | Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma | The First Affiliated Hospital of Soochow University | Observational | Not yet recruiting | Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609446) |
| April 14, 2026 | NCT07528781 | Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant Volume | Germans Trias i Pujol Hospital | Observational | Recruiting | Moderate or Severe Mitral Regurgitation | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07528781) |
| January 8, 2026 | NCT07328035 | Remission in Adults With Severe Asthma in Thailand | Thammasat University | Observational | Recruiting | Severe Asthma, Asthma Control Level | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07328035) |
| December 12, 2025 | NCT07278921 | Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of... | Sponsor not shown (see the record) | Observational | Recruiting | Relapsed/Refractory Follicular Lymphoma | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07278921) |
| December 4, 2025 | NCT07263490 | PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) | Copenhagen University Hospital, Hvidovre | Observational | Recruiting | Pre-eclampsia, Oocyte Donation, Pre-Eclampsia; Complicating Pregnancy, Pre-Eclampsia; Mild, Pre-Eclampsia, Severe... | 462 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263490) |
| September 24, 2025 | NCT07189806 | Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma | Hvivo | Observational | Recruiting | Asthma (Diagnosis) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189806) |
| September 4, 2025 | NCT07154823 | A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies | Tempus AI | Observational | Recruiting | Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL) | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154823) |
| August 6, 2025 | NCT07106216 | Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain Injury | University of Cambridge | Observational | Not yet recruiting | Tramatic Brain Injury | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07106216) |
| May 31, 2025 | NCT06999954 | Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform | Shwachman-Diamond Syndrome Alliance Inc | Observational | Recruiting | Shwachman-Diamond Syndrome, SDS, IBMF, Congenital Neutropenia, Heme Malignancy, Shwachman Syndrome, Inherited Bone... | 8,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06999954) |
| May 13, 2025 | NCT06967285 | Prone Positioning in ARDS: Predicting Neurological Complications Via Cerebral Hemodynamics | Sichuan Provincial People's Hospital | Observational | Recruiting | ARDS (Moderate or Severe) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06967285) |
| May 6, 2025 | NCT06958770 | Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes | National Taiwan University Hospital | Observational | Not yet recruiting | ARDS (Moderate or Severe) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06958770) |
| March 14, 2025 | NCT06878313 | Role of Elastic Power in Acute Respiratory Distress Syndrome | Hospital El Cruce | Observational | Not yet recruiting | ARDS (Moderate or Severe), Adult Patients | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06878313) |
| February 17, 2025 | NCT06830759 | Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma | AbbVie | Observational | Recruiting | Diffuse Large B-cell Lymphoma, Follicular Lymphoma | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06830759) |
| January 27, 2025 | NCT06794268 | A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing... | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Observational | Recruiting | Follicular Lymphoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06794268) |
| January 21, 2025 | NCT06785818 | Long-term Follow up Local Registry Study of Kymriah in South Korea | Novartis Pharmaceuticals | Observational | Recruiting | B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06785818) |
| January 20, 2025 | NCT06784167 | Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment | OHSU Knight Cancer Institute | Observational | Recruiting | Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06784167) |
| December 16, 2024 | NCT06734624 | The Microbiome in Blood Cancer and HLH | University of Nottingham | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06734624) |
| May 2, 2024 | NCT06396312 | Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression | Max-Planck-Institute of Psychiatry | Observational | Recruiting | Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms, Depressive; Disorder, Major, Single... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06396312) |
| April 1, 2024 | NCT06339255 | Italian Observational Study on CAR-T Therapy for Lymphoma | Sponsor not shown (see the record) | Observational | Recruiting | Diffuse Low Grade B-Cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Mantle Cell Lymphoma, Follicular... | 5,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06339255) |
| November 21, 2023 | NCT06142188 | Relmacabtagene Autoleucel in Hematologic Malignancies | Shanghai Ming Ju Biotechnology Co., Ltd. | Observational | Not yet recruiting | Lymphoma, B-Cell, Large B-cell Lymphoma, Follicular Lymphoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06142188) |
| November 14, 2023 | NCT06131801 | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06131801) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 2 |
| Ruijin Hospital | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| BAAT Medical Products B.V. | 2 |
| National Cancer Institute (NCI) | 1 |
| Hvivo | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| University of Nottingham | 1 |
| OHSU Knight Cancer Institute | 1 |
| University of Cambridge | 1 |
| Hospital El Cruce | 1 |
| National Taiwan University Hospital | 1 |
| Oncology Institute of Southern Switzerland | 1 |
| Germans Trias i Pujol Hospital | 1 |
| Max-Planck-Institute of Psychiatry | 1 |
| UCLH/UCL Joint Research Office | 1 |
| Shwachman-Diamond Syndrome Alliance Inc | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Tempus AI | 1 |
| University Hospital, Lille | 1 |
| Emory University | 1 |
| Thammasat University | 1 |
| Mundipharma (China) Pharmaceutical Co. Ltd | 1 |
| [Natera, Inc.](https://specstream.ai/data/clinical-trials/company/natera-inc) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| China | 7 |
| Italy | 4 |
| United Kingdom | 4 |
| Spain | 4 |
| Germany | 3 |
| Austria | 2 |
| Switzerland | 2 |
| France | 2 |
| Greece | 2 |
| Israel | 2 |
| Brazil | 1 |
| South Korea | 1 |
| Thailand | 1 |
| Denmark | 1 |
| Puerto Rico | 1 |
| Czechia | 1 |
| Lithuania | 1 |
| Argentina | 1 |
| Australia | 1 |
| Belgium | 1 |
| Bulgaria | 1 |
| Canada | 1 |
| Mexico | 1 |
| Portugal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Comfort food restaurants in the United States](https://specstream.ai/data/businesses/comfort-food-restaurants/united-states)
- [Medical service organizations in the United States](https://specstream.ai/data/businesses/medical-service-organizations/united-states)
- [Welding supply stores in the United States](https://specstream.ai/data/businesses/welding-supply-stores/united-states)
- [European restaurants in the United States](https://specstream.ai/data/businesses/european-restaurants/united-states)
- [Polish restaurants in the United States](https://specstream.ai/data/businesses/polish-restaurants/united-states)
- [B2B signage companies in the United States](https://specstream.ai/data/businesses/b2b-signage-companies/united-states)
